Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  News  >  Sectors  >  Healthcare

News : Sectors

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors
04/24CONMED CORP : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)
AQ
04/24BIORESTORATIVE THERAPIES, INC. : Unregistered Sale of Equity Securities (form 8-K)
AQ
04/24R1 RCM to Release First Quarter 2019 Results on May 9
GL
04/24PATENT ISSUED FOR METHOD FOR EYE SURGERY (USPTO 10,251,785) : Carl Zeiss Meditec AG
AQ
04/24BIOGEN : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
04/24SUPERNUS PHARMACEUTICALS INC : Results of Operations and Financial Condition, Financial Statements and Exhibits (form 8-K)
AQ
04/24FINDINGS FROM H. LUNDBECK A/S BROADEN UNDERSTANDING OF SCHIZOPHRENIA (IDENTIFYING AND CHARACTERIZING TREATMENT-RESISTANT SCHIZOPHRENIA IN OBSERVATIONAL DATABASE STUDIES) : Mental Health Diseases and Conditions - Schizophrenia
AQ
04/24KALVISTA PHARMACEUTICALS, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
04/24QUEST DIAGNOSTICS : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
04/24VANDA PHARMACEUTICALS INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
AQ
04/24ALIGN TECHNOLOGY : 1Q Earnings Snapshot
AQ
04/24ASSERTIO THERAPEUTICS : to Report First Quarter 2019 Financial Results After The Close of Markets on Wednesday, May 8, 2019
AQ
04/24PATENT APPLICATION TITLED “CANNABINOID EXTRACTION PROCESS USING BRINE” PUBLISHED ONLINE (USPTO 20190099696) : NextLeaf Solutions Ltd.
AQ
04/24PERKINELMER INC : Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (form 8-K)
AQ
04/24ADVERUM BIOTECHNOLOGIES, INC. (NASDAQ : ADVM) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
AQ
Discover
01:48aMITHRA PHARMACEUTICALS : Signs License and Supply Agreement for Commercialization of Myring™ in Latin and South America
PU
01:38aBAYER : strong operational start to the year
PU
01:31aELEKTA : demonstrates leadership in Precision Radiation Medicine at ESTRO 38
AQ
01:30aGERATHERM MEDICAL AG : financial figures for 2018
EQ
01:01aBONE THERAPEUTICS : announces publication of Annual Report 2018 and Extraordinary General Meeting on 23 May 2019
AQ
01:01aBIOCARTIS GROUP NV : Biocartis q1 2019 business update
GL
01:00aACACIA PHARMA : Announces positive phase 3 barhemsys® rescue treatment data to be presented at the annual congress of enhanced recovery and perioperative medicine
AQ
12:48aORYZON GENOMICS : to present vafidemstat efficacy data at the 7th World Congress on ADHD in Lisbon
PU
12:45aRAPID NUTRITION : Provides Shareholder Update
EQ
12:13aDAIICHI SANKYO : Announces the Sale of Its Nihonbashi Building in Japan
PU
04/24Aequus Provides Financial Year End Financial Highlights
GL
04/24DIPLOMAT PHARMACY 24 HOUR DEADLINE ALERT : Approximately 24 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Class Action Lawsuit against Diplomat Pharmacy, Inc. - DPLO
BU
04/24SANBIO : SB623, an Investigational Product, Granted Advanced Therapy Medicinal Product Classification by European Medicines Agency
BU
04/24Pomerantz Law Firm Investigates Claims On Behalf of Investors of AAC Holdings, Inc. - AAC
PR
04/24BUMRUNGRAD HOSPITAL PUBLIC : Notification of the resolutions of Annual General Meeting of Shareholders No. 26 in year 2019 of Bumrungrad Hospital Public Company Limited
PU
04/24BUMRUNGRAD HOSPITAL PUBLIC : Management Discussion and Analysis Quarter 1 Ending 31 Mar 2019
PU
04/24BUMRUNGRAD HOSPITAL PUBLIC : Reviewed Quarter 1 and Consolidated F/S (F45-3)
PU
04/24GRITSTONE ONCOLOGY : Announces Pricing of $74.8 Million Public Offering of Common Stock
AQ
04/24Gritstone Oncology Announces Pricing of $74.8 Million Public Offering of Common Stock
GL
04/24VALENS GROWORKS : Reports Record $2.2 Million in Revenue in the First Quarter of Fiscal 2019
AQ
04/24SPEAKEASY CANNABIS CLUB : Closes $6.36 Million Private Placement
AQ
04/24THE CONFERENCE BOARD'S ANNUAL EMPLOYEE HEALTH CARE CONFERENCE : Health Navigation Gains Traction, Begins to Demonstrate Results
PU
04/24STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES ACC-NO : 0000925421-19-000157 (34 Act) Size: 11 KB
PU
04/24JOHNSON & JOHNSON : to Host Pharmaceutical Business Review
PR
04/24MEDICURE : to Announce Fiscal Year End 2018 Financial Results on April 29, 2019
PR
04/24BIORESTORATIVE THERAPIES, INC. (OTCMKTS : BRTX) Files An 8-K Unregistered Sales of Equity Securities
AQ
04/24CONMED CORPORATION (NASDAQ : CNMD) Files An 8-K Results of Operations and Financial Condition
AQ
04/24NAVAMEDIC ASA : Annual Report 2018
AQ
04/24ADDITIONAL PATENT PROTECTION FOR MELFLUFEN GRANTED IN THE US UNTIL 2033 : Oncopeptides Ab
AQ
04/24BOSTON SCIENTIFIC'S TRADEMARK APPLICATION FOR “FUSE” FILED : Boston Scientific
AQ
04/24REPORTS FROM NOVARTIS PHARMA AG PROVIDE NEW INSIGHTS INTO OBESITY (PATIENT NEEDS, PERCEPTIONS, AND ATTITUDINAL DRIVERS ASSOCIATED WITH OBESITY : a Qualitative Online Bulletin Board Study): Nutritional and Metabolic Diseases and Conditions - Obesity
AQ
04/24NEW NUTRIENT RESEARCH FINDINGS FROM ABBOTT LABORATORIES REPORTED (UTILIZING DIETARY NUTRIENT RATIOS IN NUTRITIONAL RESEARCH : Expanding the Concept of Nutrient Ratios To Macronutrients): Life Science Research - Nutrient Research
AQ
04/24ALLIQUA BIOMEDICAL : Annual report pursuant to Section 13 and 15(d)
PU
04/24HITGEN AND KAKEN ENTER INTO LICENSE AGREEMENT : HitGen Inc.
AQ
04/24UNI-BIO SCIENCE HK690 APPOINTS CEO, NON-EXECUTIVE DIRECTOR AND INDEPENDENT NON-EXECUTIVE DIRECTOR LEVERAGING ON DEEP INDUSTRY KNOWLEDGE TO GARNER NEW IMPETUS : Uni-Bio Science Group Limited
AQ
04/24PATENT APPLICATION TITLED “COMPUTING SYSTEM AND METHOD FOR IDENTIFYING AND VISUALIZING CEREBRAL THROMBOSIS BASED ON MEDICAL IMAGES” PUBLISHED ONLINE (USPTO 20190099145) : Infinitt Healthcare Co. Ltd.
AQ
04/24REPORTS FROM UNIVERSITY OF CALIFORNIA AT SAN DIEGO PROVIDE NEW INSIGHTS INTO MOLECULAR MEDICINE (MULTIPLE RECYCLING ROUTES : Canonical Vs. Non-canonical Mitophagy In the Heart): Health and Medicine - Molecular Medicine
AQ
04/24MEDX HEALTH SIGNS EXCLUSIVE DISTRIBUTION AGREEMENT TO LAUNCH DERMSECURE™ IN BRAZIL, WHERE SKIN CANCER IS PREVALENT : MedX Health Corp.
AQ
04/24“PROCESS FOR PREPARING AD-35” IN PATENT APPLICATION APPROVAL PROCESS (USPTO 20190100527) : Zhejiang Hisun Pharmaceutical Co. Ltd.
AQ
04/24NORDIC NANOVECTOR : Safety Review Committee Approves Advancing to Final Dosing Regimen in Phase 1 Trial of Betalutin® in DLBCL: Nordic Nanovector
AQ
04/24Ascendis Pharma A/S Announces Presentations Related to Rare Disease Endocrinology Pipeline at Upcoming Medical Conferences
GL
04/24REPORTS SUMMARIZE DYSLIPIDEMIAS FINDINGS FROM SEOUL NATIONAL UNIVERSITY (EFFICACY AND SAFETY OF TRIPLE THERAPY WITH TELMISARTAN, AMLODIPINE, AND ROSUVASTATIN IN PATIENTS WITH DYSLIPIDEMIA AND HYPERTENSION : the Jeil Telmisartan, Amlodipine, and ...): Nutritional and Metabolic Diseases and Conditions - Dyslipidemias
AQ
04/24CENTENE CORP : Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
04/24Law Offices of Howard G. Smith Announces Investigation on Behalf of Teligent, Inc. Investors (TLGT)
BU
04/24HEAT BIOLOGICS : 10-k/a -
AQ
04/24PATENT ISSUED FOR SYSTEMS AND METHODS FOR MONITORING AND CORRECTING DEFECTS AND TUBING INSTALLATION ERRORS FOR BLOOD PROCESSING SYSTEMS (USPTO 10,254,916) : Fenwal Inc.
AQ
04/24VANDA PHARMACEUTICALS INC. (NASDAQ : VNDA) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
AQ
04/24VERITAS FARMS, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)
AQ
04/24CONMED : 1Q Earnings Snapshot
AQ
04/24ALIGN TECHNOLOGY : Q1 Financial Results Show Revenue Up
AQ
03:01aHCA HOSPITAL AMERICA : Volunteer at HCA Healthcare/HealthONE's Swedish Medical Center Named National Frist Humanitarian Awards Finalist
AQ
02:16aMEDICA : Jo Easton Appointed Non-Executive Director
PU
02:01aBONESUPPORT : publ) - Q1 2019 Interim Report - invitation to conference call and webcast
AQ
02:01aNOVACYT S.A. : Update on Notice of Full Year Results
BU
02:01aGELESIS : Awarded $10.6 (€9.4) Million Grant to Support Commercial Manufacturing of PLENITY™
BU
Prev.1  2  3  4   5  6  7  8  9  10Next
Advertisement